Host Phenotype Characteristics and MC1R in Relation to Early-onset Basal Cell Carcinoma

Overview

Journal J Invest Dermatol

Publisher Elsevier

Specialty Dermatology

Date 2011 Dec 14

PMID 22158557

Citations 19

Authors

Leah M Ferrucci

Brenda Cartmel

Annette M Molinaro

Patricia B Gordon

David J Leffell

Allen E Bale

Susan T Mayne

Affiliations

Soon will be listed here.

Abstract

Basal cell carcinoma (BCC) incidence is increasing, particularly among adults under the age of 40 years. Pigment-related characteristics are associated with BCC in older populations, but epidemiologic studies among younger individuals and analyses of phenotype-genotype interactions are limited. We examined self-reported phenotypes and melanocortin 1 receptor gene (MC1R) variants in relation to early-onset BCC. BCC cases (n=377) and controls with benign skin conditions (n=390) under the age of 40 years were identified through Yale's Dermatopathology database. Factors most strongly associated with early-onset BCC were skin reaction to first summer sun for 1 hour (severe sunburn vs. tan odds ratio (OR)=12.27, 95% confidence interval (CI)=4.08-36.94) and skin color (very fair vs. olive OR=11.06, 95% CI=5.90-20.74). Individuals with two or more MC1R non-synonymous variants were 3.59 times (95% CI=2.37-5.43) more likely to have BCC than those without non-synonymous variants. All host characteristics and MC1R were more strongly associated with multiple BCC case status (37% of cases) than a single BCC case status. MC1R, number of moles, skin reaction to first summer sun for 1 hour, and hair and skin color were independently associated with BCC. BCC risk conferred by MC1R tended to be stronger among those with darker pigment phenotypes, traditionally considered to be at low risk of skin cancer.

Citing Articles

Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma.

Hoashi T, Kanda N, Saeki H Int J Mol Sci. 2022; 23(19).

PMID: 36233269 PMC: 9570397. DOI: 10.3390/ijms231911968.

Risk of Nonmelanoma Skin Cancers and Parkinson's Disease-Meta-Analysis and Systematic Review.

Krasowska D, Gerkowicz A, Mlak R, Leziak M, Malecka-Massalska T, Krasowska D Cancers (Basel). 2021; 13(4).

PMID: 33546132 PMC: 7913207. DOI: 10.3390/cancers13040587.

Basal Cell Carcinoma: A Comprehensive Review.

Dika E, Scarfi F, Ferracin M, Broseghini E, Marcelli E, Bortolani B Int J Mol Sci. 2020; 21(15).

PMID: 32759706 PMC: 7432343. DOI: 10.3390/ijms21155572.

Cross-sectional assessment of ultraviolet radiation-related behaviors among young people after a diagnosis of melanoma or basal cell carcinoma.

Ferrucci L, Cartmel B, Clare R, Choy C, Kershaw T, Leffell D J Am Acad Dermatol. 2018; 79(1):149-152.

PMID: 29291957 PMC: 6004335. DOI: 10.1016/j.jaad.2017.12.056.

The activation of PPARγ by 2,4,6-Octatrienoic acid protects human keratinocytes from UVR-induced damages.

Flori E, Mastrofrancesco A, Kovacs D, Bellei B, Briganti S, Maresca V Sci Rep. 2017; 7(1):9241.

PMID: 28835664 PMC: 5569026. DOI: 10.1038/s41598-017-09578-3.

References

. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer. 2006; 120(5):1116-22. DOI: 10.1002/ijc.22453. View

Bakos R, Kriz M, Muhlstadt M, Kunte C, Ruzicka T, Berking C . Risk factors for early-onset basal cell carcinoma in a German institution. Eur J Dermatol. 2011; 21(5):705-9. DOI: 10.1684/ejd.2011.1436. View

Maia M, Proenca N, DE MORAES J . Risk factors for basal cell carcinoma: a case-control study. Rev Saude Publica. 1995; 29(1):27-37. DOI: 10.1590/s0034-89101995000100006. View

Eves P, Haycock J, Layton C, Wagner M, Kemp H, Szabo M . Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. Br J Cancer. 2003; 89(10):2004-15. PMC: 2394449. DOI: 10.1038/sj.bjc.6601349. View

Koppula S, Robbins L, Lu D, Baack E, White Jr C, Swanson N . Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects. Hum Mutat. 1997; 9(1):30-6. DOI: 10.1002/(SICI)1098-1004(1997)9:1<30::AID-HUMU5>3.0.CO;2-T. View

Ichii-Jones F, Lear J, Heagerty A, Smith A, Hutchinson P, Osborne J . Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol. 1998; 111(2):218-21. DOI: 10.1046/j.1523-1747.1998.00287.x. View

Arits A, Schlangen M, Nelemans P, Kelleners-Smeets N . Trends in the incidence of basal cell carcinoma by histopathological subtype. J Eur Acad Dermatol Venereol. 2010; 25(5):565-9. DOI: 10.1111/j.1468-3083.2010.03839.x. View

Levi F, Te V, Randimbison L, Erler G, La Vecchia C . Trends in skin cancer incidence in Vaud: an update, 1976-1998. Eur J Cancer Prev. 2001; 10(4):371-3. DOI: 10.1097/00008469-200108000-00011. View

Getting S . Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther. 2006; 111(1):1-15. DOI: 10.1016/j.pharmthera.2005.06.022. View

10.

GORLIN R, GOLTZ R . Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med. 1960; 262:908-12. DOI: 10.1056/NEJM196005052621803. View

11.

Bath-Hextall F, Leonardi-Bee J, Smith C, Meal A, Hubbard R . Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer. 2007; 121(9):2105-2108. DOI: 10.1002/ijc.22952. View

12.

Naldi L, DiLandro A, DAvanzo B, Parazzini F . Host-related and environmental risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control study. J Am Acad Dermatol. 2000; 42(3):446-52. DOI: 10.1016/s0190-9622(00)90217-2. View

13.

Box N, Duffy D, IRVING R, Russell A, Chen W, Griffyths L . Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol. 2001; 116(2):224-9. DOI: 10.1046/j.1523-1747.2001.01224.x. View

14.

Dessinioti C, Antoniou C, Katsambas A, Stratigos A . Basal cell carcinoma: what's new under the sun. Photochem Photobiol. 2010; 86(3):481-91. DOI: 10.1111/j.1751-1097.2010.00735.x. View

15.

Madan V, Lear J, Szeimies R . Non-melanoma skin cancer. Lancet. 2010; 375(9715):673-85. DOI: 10.1016/S0140-6736(09)61196-X. View

16.

Vitasa B, Taylor H, Strickland P, Rosenthal F, West S, Abbey H . Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer. 1990; 65(12):2811-7. DOI: 10.1002/1097-0142(19900615)65:12<2811::aid-cncr2820651234>3.0.co;2-u. View

17.

Bastiaens M, ter Huurne J, Kielich C, Gruis N, Westendorp R, Vermeer B . Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet. 2001; 68(4):884-94. PMC: 1275642. DOI: 10.1086/319500. View

18.

Scherer D, Lorenzo Bermejo J, Rudnai P, Gurzau E, Koppova K, Hemminki K . MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism. Int J Cancer. 2007; 122(8):1787-93. DOI: 10.1002/ijc.23257. View

19.

Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W . Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol. 2001; 117(2):294-300. DOI: 10.1046/j.0022-202x.2001.01421.x. View

20.

Palmer J, Duffy D, Box N, Aitken J, OGorman L, Green A . Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?. Am J Hum Genet. 2000; 66(1):176-86. PMC: 1288324. DOI: 10.1086/302711. View